Carrying amount as of the balance sheet date, which is the cumulative amount paid and (if applicable) the fair value of any noncontrolling interest in the acquiree, adjusted for any amortization recognized prior to the adoption of any changes in generally accepted accounting principles (as applicable) and for any impairment charges, in excess of the fair value of net assets acquired in one or more business combination transactions.

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 142
-Paragraph 45
-Subparagraph e
-Clause 1
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 142
-Paragraph 43
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 141R
-Paragraph 68
-Subparagraph l
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 142
-Paragraph 45
-Subparagraph e
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 141R
-Paragraph 34
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 20
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6905597&loc=d3e13816-109267

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 20
-Section 45
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6388280&loc=d3e13770-109266

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 141R
-Paragraph 72
-Subparagraph d
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

+ Details

- Definition

The aggregate amount of goodwill acquired in the period and allocated to the reportable segment. The value is stated at fair value based on the purchase price allocation.

+ References+ Details

INTANGIBLE ASSETS AND GOODWILL (Details3) (USD $) In Thousands	6 Months Ended				6 Months Ended			6 Months Ended
	Jun. 30, 2011	Jun. 30, 2011 Valeant Pharmaceuticals International ("Valeant") U.S. Neurology and Other	Jun. 30, 2011 U.S. Neurology and Other	Dec. 31, 2010 U.S. Neurology and Other	Jun. 30, 2011 Valeant Pharmaceuticals International ("Valeant") U.S. Dermatology	Jun. 30, 2011 U.S. Dermatology	Dec. 31, 2010 U.S. Dermatology	Jun. 30, 2011 Valeant Pharmaceuticals International ("Valeant") Canada and Australia	Jun. 30, 2011 PharmaSwiss S.A. Canada and Australia	Jun. 30, 2011 Canada and Australia	Jun. 30, 2011 Valeant Pharmaceuticals International ("Valeant") Branded Generics - Europe	Jun. 30, 2011 PharmaSwiss S.A. Branded Generics - Europe	Jun. 30, 2011 Branded Generics - Europe	Jun. 30, 2011 Valeant Pharmaceuticals International ("Valeant") Branded Generics - Latin America	Jun. 30, 2011 Branded Generics - Latin America
Changes in the carrying amount of goodwill
Balance at the beginning of the period	$ 3,001,376		$ 1,566,764	$ 1,379,516		$ 498,170	$ 498,508			$ 394,787			$ 352,736		$ 375,829
Additions	177,545								5,388			172,157
Adjustments	116,466	187,248			(338)			(32,963)			(24,623)			(12,858)
Foreign exchange and other	63,530									16,271			25,165		22,094
Balance at the end of the period	$ 3,358,917		$ 1,566,764	$ 1,379,516		$ 498,170	$ 498,508			$ 383,483			$ 525,435		$ 385,065